Organization
Onconic Therapeutics
3 clinical trials
Clinical trial
A Randomized, Open-label, Crossover Phase 1 Clinical Trial to Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral Single Dose of JP-1366 Tablet in Healthy VolunteersStatus: Not yet recruiting, Estimated PCD: 2023-04-01
Clinical trial
Phase I Study to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-10-09
Clinical trial
A Multicenter, Parallel, Double-blind, Randomized, Active-controlled, Non-inferiority, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 Treatment in the Prevention of (NSAIDs)-Induced Peptic UlcersStatus: Not yet recruiting, Estimated PCD: 2027-08-01